AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2015 Earnings Release
July 10 2015 - 1:30PM
Business Wire
AmerisourceBergen Corporation (NYSE: ABC) today announced that
it plans to release its results for the Third Quarter Fiscal 2015
on Thursday, July 23, 2015 prior to the opening of trading on the
New York Stock Exchange. The Company will host a conference call to
discuss the results at 11:00 a.m. Eastern Time on July 23,
2015.
Participating in the conference call will be:
Steven H. Collis, President & Chief
Executive OfficerTim G. Guttman, Executive Vice President &
Chief Financial Officer
The dial-in number for the live call will be (612) 234-9960. No
access code is required. The live call will also be webcast via the
Company’s website at www.amerisourcebergen.com. Users are encouraged to
log on to the webcast approximately 10 minutes in advance of the
scheduled start time of the call.
Replays of the call will be made available via telephone and
webcast. A replay of the webcast will be posted on www.amerisourcebergen.com approximately two hours
after the completion of the call and will remain available for
thirty days. The telephone replay will also be available
approximately two hours after the completion of the call and will
remain available for seven days. To access the telephone replay
from within the US, dial (800) 475-6701. From outside the US, dial
(320) 365-3844. The access code for the replay is 364195.
About AmerisourceBergen
AmerisourceBergen is one of the largest global pharmaceutical
sourcing and distribution services companies, helping both
healthcare providers and pharmaceutical and biotech manufacturers
improve patient access to products and enhance patient care. With
services ranging from drug distribution and niche premium logistics
to reimbursement and pharmaceutical consulting services,
AmerisourceBergen delivers innovative programs and solutions across
the pharmaceutical supply channel in human medicine and animal
health. With over $120 billion in annual revenue, AmerisourceBergen
is headquartered in Valley Forge, PA, and employs approximately
16,000 people. AmerisourceBergen is ranked #16 on the Fortune 500
list. For more information, go to www.amerisourcebergen.com.
AmerisourceBergen's Cautionary Note Regarding Forward-Looking
Statements
Certain of the statements contained in this press release are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Words such as "expect," "likely," "outlook,"
"forecast," "would," "could," "should," "can," "will," "project,"
"intend," "plan," "continue," "sustain," "synergy," "on track,"
"believe," "seek," "estimate," "anticipate," "may," "possible,"
"assume," variations of such words, and similar expressions are
intended to identify such forward-looking statements. These
statements are based on management's current expectations and are
subject to uncertainty and change in circumstances. These
statements are not guarantees of future performance and are based
on assumptions that could prove incorrect or could cause actual
results to vary materially from those indicated. Among the factors
that could cause actual results to differ materially from those
projected, anticipated, or implied are the following: competition;
industry consolidation of both customers and suppliers resulting in
increasing pressure to reduce prices for our products and services;
changes in pharmaceutical market growth rates; price inflation in
branded and generic pharmaceuticals and price deflation in
generics; declining economic conditions in the United States and
abroad; financial market volatility and disruption; substantial
defaults in payment, material reduction in purchases by or the
loss, bankruptcy or insolvency of a major customer; the loss,
bankruptcy or insolvency of a major supplier; changes to the
customer or supplier mix; the retention of key customer or supplier
relationships under less favorable economics or the adverse
resolution of any contract or other dispute with customers or
suppliers; interest rate and foreign currency exchange rate
fluctuations; the disruption of AmerisourceBergen's cash flow and
ability to return value to its stockholders in accordance with its
past practices; risks associated with the strategic, long-term
relationship between Walgreen Boots Alliance, Inc. and
AmerisourceBergen, including with respect to the pharmaceutical
distribution agreement and/or the global sourcing joint venture;
risks associated with the potential impact on AmerisourceBergen's
earnings per share resulting from the issuance of the warrants to
subsidiaries of Walgreen Boots Alliance, Inc. (the "Warrants");
AmerisourceBergen's inability to implement its hedging strategy to
mitigate the potentially dilutive effect of the issuance of its
common stock in accordance with the Warrants under its special
share repurchase program due to its financial performance, the
current and future share price of its common stock, its expected
cash flows, competing priorities for capital, and overall market
conditions; changes in the United States healthcare and regulatory
environment; increasing governmental regulations regarding the
pharmaceutical supply channel; federal and state government
enforcement initiatives to detect and prevent suspicious orders of
controlled substances and the diversion of controlled substances;
federal and state prosecution of alleged violations of related laws
and regulations, and any related litigation, including shareholder
derivative lawsuits or other disputes relating to our distribution
of controlled substances; increased federal scrutiny and qui tam
litigation for alleged violations of fraud and abuse laws and
regulations and/or any other laws and regulations governing the
marketing, sale, purchase and/or dispensing of pharmaceutical
products or services and any related litigation; material adverse
resolution of pending legal proceedings; declining reimbursement
rates for pharmaceuticals; the acquisition of businesses that do
not perform as expected, or that are difficult to integrate or
control, including the integration of recently-acquired MWI or
ability to capture all of the anticipated synergies related
thereto; managing foreign expansion, including non-compliance with
the U.S. Foreign Corrupt Practices Act, anti-bribery laws and
economic sanctions and import laws and regulations; malfunction,
failure or breach of the sophisticated information systems to
operate as designed; risks generally associated with data privacy
regulation and the international transfer of personal data; changes
in tax laws or legislative initiatives that could adversely affect
AmerisourceBergen's tax positions and/or AmerisourceBergen's tax
liabilities or adverse resolution of challenges to
AmerisourceBergen's tax positions; natural disasters or other
unexpected events that affect AmerisourceBergen's operations; and
other economic, business, competitive, legal, tax, regulatory
and/or operational factors affecting AmerisourceBergen's business
generally. Certain additional factors that management believes
could cause actual outcomes and results to differ materially from
those described in forward-looking statements are set forth (i) in
Item 1A (Risk Factors) and Item 1 (Business) in the Company’s
Annual Report on Form 10-K for the fiscal year ended September 30,
2014 and elsewhere in that report and (ii) in other reports.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150710005643/en/
AmerisourceBergen CorporationBarbara
Brungess, 610-727-7199bbrungess@amerisourcebergen.com
AmerisourceBergen (NYSE:ABC)
Historical Stock Chart
From Aug 2024 to Sep 2024
AmerisourceBergen (NYSE:ABC)
Historical Stock Chart
From Sep 2023 to Sep 2024